Quick Takeaways
- Panacea Innovation Ltd filed SCHEDULE 13G for Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (ATRA).
- Disclosed ownership: 9.5%.
- Date of event: 30 Jan 2025.
Quoteable Key Fact
"Panacea Innovation Ltd disclosed 9.5% ownership in Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (ATRA) on 30 Jan 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Panacea Venture Healthcare Fund II, L.P. | 9.5% | 550,000 | 0 | 550,000 | By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang | James Huang, Founding Managing Partner | |
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 9.5% | 550,000 | 0 | 550,000 | By: Panacea Innovation Limited, its sole owner, /s/ James Huang | James Huang, Founding Managing Partner | |
| Panacea Innovation Limited | 9.5% | 550,000 | 0 | 550,000 | /s/ James Huang | James Huang, Founding Managing Partner | |
| James Huang | 9.5% | 550,000 | 0 | 550,000 | /s/ James Huang | James Huang |